Oncotherpapy Science (4564.TSE) Q2 2026 Earnings

8MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1
-1
-1
-0

Details

Expected EPS
N/A
Actual EPS
-0
Surprise EPS
-0
Surprise Percent
+∞%

Description

Oncotherpapy Science (4564.TSE) has reported earnings of -0 per share for Q2 2026.

0 Comments

Share your thoughts